Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.
Saved in:
| Title: | Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models. |
|---|---|
| Authors: | Li, Shulin1 (AUTHOR), Hoefnagel, Sanne J. M.1,2 (AUTHOR), Read, Matthew3,4 (AUTHOR), Meijer, Sybren5 (AUTHOR), van Berge Henegouwen, Mark I.6 (AUTHOR), Gisbertz, Suzanne S.6 (AUTHOR), Bonora, Elena7 (AUTHOR), Liu, David S. H.8,9 (AUTHOR), Phillips, Wayne A.4,10 (AUTHOR), Calpe, Silvia1 (AUTHOR), Correia, Ana C. P.1 (AUTHOR), Sancho-Serra, Maria D. C.1 (AUTHOR), Mattioli, Sandro7,11 (AUTHOR), Krishnadath, Kausilia K.1,2,12,13 (AUTHOR) Sheila.Krishnadath@uza.be |
| Source: | Cellular Oncology (2211-3428). Aug2022, Vol. 45 Issue 4, p639-658. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
